1-74236103-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BS2_Supporting
The NM_015978.3(TNNI3K):c.42T>A(p.Asp14Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000081 in 1,604,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015978.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNNI3K | NM_015978.3 | c.42T>A | p.Asp14Glu | missense_variant, splice_region_variant | 2/25 | ENST00000326637.8 | NP_057062.1 | |
FPGT-TNNI3K | NM_001112808.3 | c.345T>A | p.Asp115Glu | missense_variant, splice_region_variant | 4/27 | NP_001106279.3 | ||
FPGT-TNNI3K | NM_001199327.2 | c.345T>A | p.Asp115Glu | missense_variant, splice_region_variant | 4/24 | NP_001186256.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNNI3K | ENST00000326637.8 | c.42T>A | p.Asp14Glu | missense_variant, splice_region_variant | 2/25 | 1 | NM_015978.3 | ENSP00000322251 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151558Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247662Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133926
GnomAD4 exome AF: 0.00000551 AC: 8AN: 1452390Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 2AN XY: 722582
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151676Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74128
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 08, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with TNNI3K-related conditions. This variant is present in population databases (rs144055969, gnomAD 0.02%). This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 14 of the TNNI3K protein (p.Asp14Glu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at